SCHEMBL29601706

SCHEMBL29601706

CC(=O)c1ncccc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ATM Q13315 1/20 0.46
ALDH1A1 P00352 2/20 0.46
HCRTR1 O43613 6/20 0.45
HCRTR2 O43614 6/20 0.45
MAPT P10636 2/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
AGER Q15109 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
MKNK1 Q9BUB5 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6902624 1.00 KDM4E (0.46) KDM4EATMALDH1A1HCRTR1HCRTR2
SCHEMBL30578386 0.98 KDM4E (0.45) KDM4EATMALDH1A1HCRTR1HCRTR2
SCHEMBL287699 0.85 KDM4E (0.57) KDM4EATMALDH1A1HCRTR1HCRTR2
SCHEMBL11298868 0.85 KDM4E (0.49) KDM4EATMALDH1A1HCRTR1HCRTR2
SCHEMBL231896 0.81 MKNK1 (0.56) KDM4EATMALDH1A1HCRTR1HCRTR2
SCHEMBL17878183 0.81 KDM4E (0.46) KDM4EATMALDH1A1HCRTR1HCRTR2
SCHEMBL17449213 0.81 ALDH1A1 (0.44) KDM4EALDH1A1HCRTR1MAPTCYP3A4
SCHEMBL31278612 0.81 ALDH1A1 (0.44) KDM4EALDH1A1HCRTR1MAPTCYP3A4
SCHEMBL19599254 0.81 KDM4E (0.47) KDM4EATMALDH1A1HCRTR1HCRTR2
SCHEMBL19564493 0.81 KDM4E (0.43) KDM4EATMALDH1A1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 CN disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed